Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEUROMETRIX, INC.

(NURO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NEUROMETRIX, INC.
10/22NEUROMETRIX, INC. : Entry into a Material Definitive Agreement, Financial Statements and E..
AQ
10/21NEUROMETRIX : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
10/21NEUROMETRIX : Reports Q3 2021 Financial Results - Form 8-K
PU
10/21NEUROMETRIX, INC. : Results of Operations and Financial Condition, Financial Statements an..
AQ
10/21NeuroMetrix Reports Q3 2021 Financial Results
GL
10/14NeuroMetrix, Inc. Announces Date for Third Quarter 2021 Financial Results Conference Ca..
GL
10/07NEUROMETRIX : Announces Submission of FDA De Novo Request for Treatment of Fibromyalgia Sy..
AQ
10/06NeuroMetrix Announces Submission of FDA De Novo Request for Treatment of Fibromyalgia S..
GL
10/05NEUROMETRIX : Announces Participation in the Center to Stream Healthcare In Place (C2SHIP)..
AQ
08/13NEUROMETRIX : Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in ..
PU
08/13NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/26NEUROMETRIX : Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its ..
AQ
07/22NEUROMETRIX : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
07/22NEUROMETRIX : Reports Q2 2021 Financial Results (Form 8-K)
PU
07/22NEUROMETRIX, INC. : Results of Operations and Financial Condition, Financial Statements an..
AQ
07/22NEUROMETRIX : Reports Q2 2021 Financial Results
AQ
07/20NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia ..
GL
07/15NEUROMETRIX : Announces Date for Second Quarter 2021 Financial Results Conference Call
AQ
06/30NEUROMETRIX, INC. : Termination of a Material Definitive Agreement (form 8-K)
AQ
06/25NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/15NeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica ..
GL
06/11NEUROMETRIX : THIRD AMENDED AND RESTATED BY-LAWS OF (Form 8-K)
PU
06/11NEUROMETRIX, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Finan..
AQ
06/09NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell..
GL
05/11NEUROMETRIX, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04/27NEUROMETRIX, INC. : Other Events (form 8-K)
AQ
04/22NEUROMETRIX : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
04/22NEUROMETRIX, INC. : Results of Operations and Financial Condition, Financial Statements an..
AQ
04/22NeuroMetrix Reports Q1 2021 Financial Results
GL
04/15NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Ca..
GL
04/15NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/26NEUROMETRIX, INC. : Change in Directors or Principal Officers, Financial Statements and Ex..
AQ
01/29NEUROMETRIX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF O..
AQ
01/28NEUROMETRIX, INC. : Results of Operations and Financial Condition, Financial Statements an..
AQ
01/28NeuroMetrix Reports Q4 and Full Year 2020 Financial Results
GL
01/25NEUROMETRIX : Announces Date for Fourth Quarter and Full Year 2020 Financial Results Confe..
AQ
01/22NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Result..
GL
2020NEUROMETRIX, INC. : Change in Directors or Principal Officers, Financial Statements and Ex..
AQ
2020NEUROMETRIX : Reports Q3 2020 Financial Results
AQ
2020NEUROMETRIX : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
2020NEUROMETRIX, INC. : Results of Operations and Financial Condition, Financial Statements an..
AQ
2020NEUROMETRIX : Reports Q3 2020 Financial Results
AQ
2020NeuroMetrix Reports Q3 2020 Financial Results
GL
2020NEUROMETRIX : Announces Date for Third Quarter 2020 Financial Results Conference Call
AQ
2020NEUROMETRIX : Announces Date for Third Quarter 2020 Financial Results Conference Call
AQ
2020NeuroMetrix, Inc. Announces Date for Third Quarter 2020 Financial Results Conference Ca..
GL
2020NEUROMETRIX : Launches Quell App for Apple Watch, the First Smartwatch App for an Over-the..
AQ
2020NEUROMETRIX : Launches Quell® App for Apple Watch®, the First Smartwatch App for an Over-t..
AQ
2020NeuroMetrix Launches Quell® App for Apple Watch®, the First Smartwatch App for an Over-..
GL
2020NEUROMETRIX : Announces Issuance of New U.S. Patent for Quell® Wearable Technology
AQ
2020NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology
GL
2020NeuroMetrix Reports Scientific Presentation at the PAINWeek 2020 Live Virtual Conferenc..
GL
2020NEUROMETRIX : Reports Publication of Study Validating DPNCheck Staging of Diabetic Periphe..
AQ
2020NeuroMetrix Reports Publication of Study Validating DPNCheck® Staging of Diabetic Perip..
GL
2020NEUROMETRIX : Reports that Quell is to be evaluated for Chemotherapy-Induced Peripheral Ne..
AQ
2020NeuroMetrix Reports that Quell® is to be Evaluated for Chemotherapy-Induced Peripheral ..
GL
2020NEUROMETRIX : Quell Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
AQ
2020Quell® Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
GL
2020NEUROMETRIX : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
2020NEUROMETRIX, INC. : Results of Operations and Financial Condition, Financial Statements an..
AQ
2020NeuroMetrix Reports Q2 2020 Financial Results
GL
2020NeuroMetrix, Inc. Announces Date for Second Quarter 2020 Financial Results Conference C..
GL
2020NEUROMETRIX : Reports DPNCheck Expansion in China
AQ
2020NeuroMetrix Reports DPNCheck® Expansion in China
GL
2020NeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix
GL
2020NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020NEUROMETRIX : to Target Chronic Knee Pain with Quell 2.0 Wearable Pain Relief Device
AQ
2020NeuroMetrix to Target Chronic Knee Pain with Quell® 2.0 Wearable Pain Relief Device
GL
2020NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020NEUROMETRIX, INC. : Other Events (form 8-K)
AQ
2020NEUROMETRIX, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Finan..
AQ
2020NEUROMETRIX, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020NEUROMETRIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
1  2Next
Upcoming event on NEUROMETRIX, INC.
01/27/22